Literature DB >> 215785

Cell-free translation of purified virion-associated high-molecular-weight RNA synthesized in vitro by vaccinia virus.

W Bossart, E Paoletti, D L Nuss.   

Abstract

Virion-associated high-molecular-weight (HMW) RNA synthesized in vitro by purified vaccinia virus particles has been translated in a wheat germ cell-free protein synthesizing system. Purified HMW RNA directs the synthesis of translation products which are identical to the translation products made in response to in vitro-synthesized, virion-released 8 to 12S mRNA. The translation of HMW RNA proceeds exclusively through a 5'-terminal cap-mediated initiation step. Furthermore, only one coding sequence is translated per HMW RNA molecule, and that sequence is probably located near the 5' end of the molecule. These conclusions are based on the following results. (i) Sodium dodecyl sulfate--polyacrylamide gel electrophoresis patterns of translation products synthesized in response to HMW RNA and in response to 8 to 12S mRNA were qualitatively identical. (ii) On an equal weight basis, HMW RNA was 25 to 30% as active as 8 to 12S mRNA in stimulating in vitro protein synthesis. (iii) Unmethylated HMW RNA was translated at 10% the efficiency of the methylated form of this RNA. (iv) m7pG inhibited the translation of fully methylated HMW RNA by 90%. (v) After the initiation step of translation was blocked by aurintricarboxylic acid, the rate with which amino acids were incorporated into individual polypeptides decreased in a similar manner for the translation of both HMW RNA and 8 to 12S mRNA. Virion-released 8 to 12S mRNA derived from virion-associated HMW RNA during a chase in the presence of ATP, GTP, and S-adenosylmethionine was also translated. At low RNA concentrations, the derived RNA appeared to stimulate amino acid incorporation more efficiently than the HMW RNA precursor. However, at higher concentrations of this RNA, protein synthesis was severely inhibited.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 215785      PMCID: PMC525815     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  36 in total

1.  The preparation and characteristics of highly purified radioactively labelled poxvirus.

Authors:  W K JOKLIK
Journal:  Biochim Biophys Acta       Date:  1962-08-20

2.  An amazing sequence arrangement at the 5' ends of adenovirus 2 messenger RNA.

Authors:  L T Chow; R E Gelinas; T R Broker; R J Roberts
Journal:  Cell       Date:  1977-09       Impact factor: 41.582

3.  Transcriptional complexity of vaccinia virus in vivo and in vitro.

Authors:  E Paoletti; L J Grady
Journal:  J Virol       Date:  1977-09       Impact factor: 5.103

4.  Use of coupled transcription and translation to study mRNA production by vaccinia cores.

Authors:  H R Pelham
Journal:  Nature       Date:  1977-10-06       Impact factor: 49.962

5.  Methyl group analysis of virion-associated high-molecular-weight RNA synthesized in vitro by purified vaccinia virus.

Authors:  D L Nuss; E Paoletti
Journal:  J Virol       Date:  1977-07       Impact factor: 5.103

6.  Translational control: recognition of the methylated 5' end and an internal sequence in eukaryotic mRNA by the initiation factor that binds methionyl-tRNAfMet.

Authors:  R Kaempfer; H Rosen; R Israeli
Journal:  Proc Natl Acad Sci U S A       Date:  1978-02       Impact factor: 11.205

7.  Ribonucleic acid synthesis in vaccinia virus. II. Synthesis of polyriboadenylic acid.

Authors:  J Kates; J Beeson
Journal:  J Mol Biol       Date:  1970-05-28       Impact factor: 5.469

8.  High molecular weight virion-associated RNA of vaccinia. A possible precursor to 8 to 12 S mRNA.

Authors:  E Paoletti
Journal:  J Biol Chem       Date:  1977-02-10       Impact factor: 5.157

9.  The role of ATP in the biogenesis of vaccinia virus mRNA in vitro.

Authors:  E Paoletti; B R Lipinskas
Journal:  Virology       Date:  1978-06-15       Impact factor: 3.616

10.  Characterization of the nucleoside triphosphate phosphohydrolase (ATPase) activity of RNA synthesi termination factor p. I. Enzymatic properties and effects of inhibitors.

Authors:  C Lowery; J P Richardson
Journal:  J Biol Chem       Date:  1977-02-25       Impact factor: 5.157

View more
  7 in total

1.  Expression of wound tumor virus gene products in vivo and in vitro.

Authors:  D L Nuss; A J Peterson
Journal:  J Virol       Date:  1980-05       Impact factor: 5.103

2.  Structural proteins and cell-free translation products of total RNA and hybrid-selected RNA from two DNA variants of vaccinia virus.

Authors:  D L Bedard
Journal:  J Virol       Date:  1983-05       Impact factor: 5.103

3.  Hybridization selection and cell-free translation of mRNA's encoded within the inverted terminal repetition of the vaccinia virus genome.

Authors:  J A Cooper; R Wittek; B Moss
Journal:  J Virol       Date:  1981-01       Impact factor: 5.103

4.  Capped and polyadenylated low-molecular-weight RNA synthesized by vaccinia virus in vitro.

Authors:  E Paoletti; B R Lipinskas; D Panicali
Journal:  J Virol       Date:  1980-01       Impact factor: 5.103

5.  The orthopoxvirus 68-kilodalton ankyrin-like protein is essential for DNA replication and complete gene expression of modified vaccinia virus Ankara in nonpermissive human and murine cells.

Authors:  Karin M Sperling; Astrid Schwantes; Caroline Staib; Barbara S Schnierle; Gerd Sutter
Journal:  J Virol       Date:  2009-04-08       Impact factor: 5.103

6.  Analysis of vaccinia virus transcriptional complexity in vitro and in vivo: characterization of RNase T1-resistant 5'-terminal oligonucleotides.

Authors:  C Whitkop; B R Lipinskas; S Mercer; D Panicali; E Paoletti
Journal:  J Virol       Date:  1982-05       Impact factor: 5.103

7.  Inhibition of Orbivirus Replication by Aurintricarboxylic Acid.

Authors:  Celia Alonso; Sergio Utrilla-Trigo; Eva Calvo-Pinilla; Luis Jiménez-Cabello; Javier Ortego; Aitor Nogales
Journal:  Int J Mol Sci       Date:  2020-10-02       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.